Bing

SEARCH HISTORY

The put seller probably likes the stock and would be willing to get long at that price. This way, he or she can squeeze a few cents from the name even if they never own it. (See our Education section for more) ASTX is up 6.08 percent to $4.36 in afternoon ...
Option MONSTER · 7/1/2013
Astex Pharmaceuticals (ASTX) recently announced that Japanese based Otsuka Pharmaceutical ... The purchase price of $8.50 per share represents a premium of 48% to Astex Pharma’s average closing stock price in the last 30 days. The total …
ZACKS · 9/6/2013
Astex Pharmaceuticals, Inc. is expected to begin trading on NASDAQ under the symbol ASTX on September 12, 2011. Astex Therapeutics Limited became a wholly owned subsidiary of SuperGen, Inc. on July 20, 2011. Further information about this …
PharmiWeb · 9/2/2011
More from Bing News
5, 2013 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. ("Otsuka") and Astex Pharmaceuticals, Inc. (ASTX) ("Astex"), announced today that ... representing a 48% premium to the average closing stock price for the prior 30 day period.
FiercePharma · 9/5/2013
April 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), today reported financial results for ... no similar amortization expense for the same prior year period. Stock-based compensation expense, a non-cash expense that is …
路透中文网 · 4/30/2012
... has assumed all outstanding stock options of Astex. In the third quarter of 2011, SuperGen intends to change its name to Astex Pharmaceuticals, Inc., and expects to be listed on NASDAQ under the symbol ASTX. The company plans to leverage its …
Drug Discovery & Development · 7/25/2011
Astex Pharmaceuticals (ASTX): Brean Capital begins the small cap stock at a Buy. Big Lots (BIG): BIG is begun with a Market Perform at FBR Capital, whose target price is $35 on a company it says is still in transitional mode. Dick's Sporting Goods (DKS ...
Minyanville · ByJustin Sharon · 7/19/2013
ASTX) has earned a coveted five-star ranking. With that in mind, let's take a closer look at Astex's business and see what CAPS investors are saying about the stock right now. Sources: S&P Capital IQ and Motley Fool CAPS. On CAPS, 96% of the 330 …
Daily Finance · 6/20/2012
Astex (ASTX) and Novartis (NVS) have Hsp90 drugs in phase two trials ... which will quickly translate into big gains for SYNTA. The stock is covered by six analysts, all of whom have a positive outlook for the stock; the consensus target price for the ...
bidnessetc.com · 2/25/2014
I got very lucky on a buy of Astex Pharmaceuticals (ASTX) this morning when it was discussed in the ... The tepid open attracted dip-buyers, who have been doing well with individual stock-picking. As I noted in my opening, the most notable aspect of ...
realmoney.thestreet.com · 9/4/2013